Source: International Congress 2018 – State of the art session: Airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Gibson (Newcastle, Australia). Macrolides, inflammation and the lung microbiome: cause or effect?. International Congress 2018 – State of the art session: Airways disease

Member's Comments

No comment yet.

Related content which might interest you: Bacterial infection and COPD - cause or effect? Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations Year: 2018 Neutrophils in chronic inflammatory airway diseases: can we target them and how? Source: Eur Respir J 2010; 35: 467-469 Year: 2010 Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations? Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 The lung microbiome and its effects on respiratory infections Source: Virtual Congress 2020 – Respiratory infections Year: 2020 The consequences of microbiome and pathogen dynamics for chronic lung diseases Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation Year: 2012 Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019 Year: 2019 How does the gut microbiota regulate immune responses in the airways? Source: Annual Congress 2006 - Can environmental exposures prevent allergic disease, what are the mechanisms and how important is timing of exposure? Year: 2006 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020 Year: 2020 The consequence of matrix dysfunction on lung immunity and the microbiome in COPD Source: Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018 Year: 2018 Oral microbiome and associations with chemical exposure, asthma and lung function Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics Year: 2017 H.p. is good for you: protective effects of helicobacter infections in airway disease Source: Annual Congress 2013 –Significance of intestinal and respiratory tract cross-talk in chronic lung diseases Year: 2013 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 LATE-BREAKING ABSTRACT: Haemophilus dominance of the stable COPD microbiome is associated with greater bacterial load and inflammation and is modulated by prophylactic antibiotic therapy Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 Effect of a small natural dietary compound on lung pathology in airway inflammation Source: International Congress 2018 – Basic pharmacology Year: 2018